Increased mRNA translation delays tumour initiation and exposes a therapeutic vulnerability in lung cancer
- DOI
- 10.1186/s12943-026-02680-z
- Published
- 2026-05-21
- Container
- Molecular Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12943-026-02680-z,
title = {Increased mRNA translation delays tumour initiation and exposes a therapeutic vulnerability in lung cancer},
author = {Luis Pardo and Madeleine Moore and Ruhi Deshmukh and Ian Powley and Joseph A. Waldron and Bjorn Kruspig and Lynn McGarry and Lobsang Dolma and America V. Campos and Colin Wood and Holly Leslie and Mark Hughes and Emanuel Jeldes and June Munro and Louise Mitchell and Leah Officer-Jones and Rachel Baird and Hugo Coquelet and Nigel B. Jamieson and David Sumpton and Douglas Strathdee and John le Quesne and Martin Bushell and Daniel J. Murphy and Jim C. Norman},
year = {2026},
journal = {Molecular Cancer},
doi = {10.1186/s12943-026-02680-z},
url = {https://doi.org/10.1186/s12943-026-02680-z}
}RIS
TY - JOUR TI - Increased mRNA translation delays tumour initiation and exposes a therapeutic vulnerability in lung cancer AU - Luis Pardo AU - Madeleine Moore AU - Ruhi Deshmukh AU - Ian Powley AU - Joseph A. Waldron AU - Bjorn Kruspig AU - Lynn McGarry AU - Lobsang Dolma AU - America V. Campos AU - Colin Wood AU - Holly Leslie AU - Mark Hughes AU - Emanuel Jeldes AU - June Munro AU - Louise Mitchell AU - Leah Officer-Jones AU - Rachel Baird AU - Hugo Coquelet AU - Nigel B. Jamieson AU - David Sumpton AU - Douglas Strathdee AU - John le Quesne AU - Martin Bushell AU - Daniel J. Murphy AU - Jim C. Norman PY - 2026 JO - Molecular Cancer DO - 10.1186/s12943-026-02680-z UR - https://doi.org/10.1186/s12943-026-02680-z ER -
APA
Pardo, L., Moore, M., Deshmukh, R., Powley, I., Waldron, J. A., Kruspig, B., McGarry, L., Dolma, L., Campos, A. V., Wood, C., Leslie, H., Hughes, M., Jeldes, E., Munro, J., Mitchell, L., Officer-Jones, L., Baird, R., Coquelet, H., Jamieson, N. B., Sumpton, D., Strathdee, D., Quesne, J. L., Bushell, M., Murphy, D. J., & Norman, J. C. (2026). Increased mRNA translation delays tumour initiation and exposes a therapeutic vulnerability in lung cancer. Molecular Cancer. https://doi.org/10.1186/s12943-026-02680-z
Source records
- crossref · retrieved 2026-09-26T08:21:27.442Z